Skip to content
10-Q

Quarterly Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-23-000504

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 5, 2023 39.83M sh
Cash And Equivalents Q1 2023 · Mar 31, 2023 $9.46K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $11.57K
Total Liabilities Q1 2023 · Mar 31, 2023 $116.37K
Total Liabilities Q1 2023 · Dec 31, 2022 $48.79K
Current Assets Q1 2023 · Mar 31, 2023 $27.38K
Current Assets Q1 2023 · Dec 31, 2022 $31.61K
Total Assets Q1 2023 · Mar 31, 2023 $27.38K
Total Assets Q1 2023 · Dec 31, 2022 $31.61K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$949
Stockholders Equity Q1 2023 · Mar 31, 2022 −$944
Stockholders Equity Q1 2023 · Dec 31, 2021 −$1.01K
Sga Expense Q1 2023 · Mar 31, 2022 $150
Net Income Q1 2023 · Mar 31, 2022 −$4.21K
Operating Income Q1 2023 · Mar 31, 2022 −$4.21K
Gross Profit Q1 2023 · Mar 31, 2022 $214
Cost Of Revenue Q1 2023 · Mar 31, 2022 $65
Revenue Q1 2023 · Mar 31, 2022 $279